NDVA.F Stock Overview
Engages in the production, processing, and sale of cannabis and cannabis related products in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Indiva Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.021 |
| 52 Week High | CA$0.095 |
| 52 Week Low | CA$0.021 |
| Beta | 1.08 |
| 11 Month Change | 0% |
| 3 Month Change | -19.73% |
| 1 Year Change | -47.63% |
| 33 Year Change | -94.46% |
| 5 Year Change | -91.27% |
| Change since IPO | -97.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| NDVA.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 2.8% | 2.2% |
| 1Y | -47.6% | 11.8% | 32.6% |
Return vs Industry: NDVA.F underperformed the US Pharmaceuticals industry which returned 16% over the past year.
Return vs Market: NDVA.F underperformed the US Market which returned 19.1% over the past year.
Price Volatility
| NDVA.F volatility | |
|---|---|
| NDVA.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: NDVA.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine NDVA.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Niel Marotta | www.indiva.com |
Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers edibles, capsules and tablets, and vape products under the No Future, Pearls by gron, Bhang Chocolate, Indiva Doppio, Indiva Blips, and Indiva 1432 brands. Indiva Limited is based in Ottawa, Canada.
Indiva Limited Fundamentals Summary
| NDVA.F fundamental statistics | |
|---|---|
| Market cap | US$4.32m |
| Earnings (TTM) | -US$3.27m |
| Revenue (TTM) | US$27.64m |
0.2x
P/S Ratio-1.3x
P/E RatioIs NDVA.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NDVA.F income statement (TTM) | |
|---|---|
| Revenue | CA$37.49m |
| Cost of Revenue | CA$26.54m |
| Gross Profit | CA$10.95m |
| Other Expenses | CA$15.39m |
| Earnings | -CA$4.44m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.023 |
| Gross Margin | 29.21% |
| Net Profit Margin | -11.83% |
| Debt/Equity Ratio | -1,692.6% |
How did NDVA.F perform over the long term?
See historical performance and comparison